| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 112 | 2022 | 3620 | 14.010 |
Why?
|
| Caenorhabditis elegans | 55 | 2018 | 1408 | 7.580 |
Why?
|
| Caenorhabditis elegans Proteins | 33 | 2018 | 857 | 5.660 |
Why?
|
| RNA, Untranslated | 11 | 2023 | 448 | 2.870 |
Why?
|
| Oncogenes | 14 | 2021 | 1246 | 2.760 |
Why?
|
| Gene Expression Regulation, Neoplastic | 29 | 2021 | 8561 | 2.400 |
Why?
|
| 3' Untranslated Regions | 14 | 2021 | 513 | 2.390 |
Why?
|
| Neoplasms | 32 | 2023 | 20514 | 2.010 |
Why?
|
| ras Proteins | 10 | 2014 | 1101 | 1.920 |
Why?
|
| RNA-Binding Proteins | 11 | 2022 | 1885 | 1.870 |
Why?
|
| RNA, Neoplasm | 5 | 2020 | 774 | 1.650 |
Why?
|
| Longevity | 11 | 2017 | 1031 | 1.630 |
Why?
|
| Genes, Tumor Suppressor | 7 | 2021 | 1092 | 1.360 |
Why?
|
| Adenosine Deaminase | 4 | 2022 | 242 | 1.300 |
Why?
|
| RNA, Helminth | 8 | 2014 | 59 | 1.250 |
Why?
|
| RNA Editing | 4 | 2022 | 156 | 1.240 |
Why?
|
| Gene Expression Regulation | 22 | 2021 | 12299 | 1.170 |
Why?
|
| Genes, Helminth | 11 | 2010 | 151 | 1.170 |
Why?
|
| Transcription Factors | 21 | 2021 | 11955 | 1.150 |
Why?
|
| Gene Expression Regulation, Developmental | 19 | 2017 | 3771 | 1.080 |
Why?
|
| Animals | 110 | 2022 | 169277 | 1.070 |
Why?
|
| Neoplasms, Glandular and Epithelial | 3 | 2015 | 509 | 1.070 |
Why?
|
| RNA, Small Untranslated | 2 | 2018 | 59 | 1.050 |
Why?
|
| Peptide Nucleic Acids | 5 | 2023 | 24 | 1.020 |
Why?
|
| Body Patterning | 7 | 2009 | 652 | 0.990 |
Why?
|
| Aging | 9 | 2017 | 8352 | 0.970 |
Why?
|
| Adenylosuccinate Lyase | 1 | 2022 | 3 | 0.930 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2018 | 4642 | 0.910 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2021 | 95 | 0.850 |
Why?
|
| Larva | 6 | 2017 | 512 | 0.850 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2023 | 436 | 0.810 |
Why?
|
| Lung Neoplasms | 14 | 2019 | 12530 | 0.790 |
Why?
|
| Cell Line, Tumor | 28 | 2022 | 16729 | 0.780 |
Why?
|
| RNA Splicing | 3 | 2021 | 870 | 0.770 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2020 | 1293 | 0.760 |
Why?
|
| Lymphoma | 4 | 2022 | 1881 | 0.750 |
Why?
|
| RNA, Small Interfering | 8 | 2018 | 3571 | 0.750 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 8 | 2016 | 1632 | 0.730 |
Why?
|
| Radiation Tolerance | 3 | 2013 | 508 | 0.720 |
Why?
|
| Cell Proliferation | 14 | 2021 | 10603 | 0.720 |
Why?
|
| Sarcoma, Kaposi | 1 | 2021 | 362 | 0.690 |
Why?
|
| RNA, Transfer | 3 | 2021 | 308 | 0.690 |
Why?
|
| DNA-Binding Proteins | 11 | 2021 | 9741 | 0.680 |
Why?
|
| Transcription, Genetic | 13 | 2021 | 7883 | 0.680 |
Why?
|
| Cell Hypoxia | 2 | 2019 | 682 | 0.680 |
Why?
|
| Herpesvirus 4, Human | 2 | 2018 | 1249 | 0.670 |
Why?
|
| Citric Acid Cycle | 1 | 2019 | 231 | 0.650 |
Why?
|
| Oligonucleotides | 1 | 2020 | 572 | 0.640 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2021 | 2984 | 0.630 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2020 | 2094 | 0.630 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2017 | 58 | 0.620 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2018 | 266 | 0.620 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 2017 | 58 | 0.610 |
Why?
|
| Repressor Proteins | 8 | 2019 | 3064 | 0.610 |
Why?
|
| RNA | 4 | 2023 | 2608 | 0.610 |
Why?
|
| RNA Processing, Post-Transcriptional | 5 | 2021 | 437 | 0.600 |
Why?
|
| Liver Neoplasms | 3 | 2020 | 4104 | 0.600 |
Why?
|
| Down-Regulation | 8 | 2019 | 3069 | 0.590 |
Why?
|
| Genes, ras | 3 | 2014 | 706 | 0.570 |
Why?
|
| Base Sequence | 15 | 2016 | 13180 | 0.530 |
Why?
|
| Epigenesis, Genetic | 6 | 2021 | 3427 | 0.520 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2018 | 785 | 0.510 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2014 | 93 | 0.510 |
Why?
|
| RNA Interference | 9 | 2021 | 2983 | 0.510 |
Why?
|
| Cell Differentiation | 8 | 2021 | 11665 | 0.510 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2014 | 176 | 0.480 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2013 | 39 | 0.480 |
Why?
|
| Transcriptional Activation | 4 | 2017 | 1840 | 0.470 |
Why?
|
| Humans | 98 | 2023 | 715636 | 0.470 |
Why?
|
| Promoter Regions, Genetic | 10 | 2021 | 6003 | 0.470 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2016 | 774 | 0.460 |
Why?
|
| Animals, Genetically Modified | 9 | 2018 | 1578 | 0.460 |
Why?
|
| src-Family Kinases | 1 | 2015 | 559 | 0.460 |
Why?
|
| Gene Expression Profiling | 10 | 2022 | 9498 | 0.450 |
Why?
|
| Introns | 3 | 2018 | 994 | 0.450 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2018 | 553 | 0.450 |
Why?
|
| Axons | 2 | 2011 | 1729 | 0.450 |
Why?
|
| Nanoparticles | 4 | 2022 | 1899 | 0.440 |
Why?
|
| Radiation, Ionizing | 1 | 2013 | 275 | 0.440 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 1245 | 0.440 |
Why?
|
| Mice | 28 | 2022 | 80320 | 0.430 |
Why?
|
| Gene Silencing | 3 | 2021 | 1602 | 0.430 |
Why?
|
| POU Domain Factors | 1 | 2011 | 40 | 0.430 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2020 | 1841 | 0.420 |
Why?
|
| Ovarian Neoplasms | 4 | 2014 | 4748 | 0.420 |
Why?
|
| Neoplastic Stem Cells | 3 | 2021 | 1371 | 0.410 |
Why?
|
| Trans-Activators | 3 | 2014 | 3051 | 0.410 |
Why?
|
| Casein Kinase Ialpha | 1 | 2010 | 25 | 0.410 |
Why?
|
| Emulsions | 1 | 2011 | 142 | 0.410 |
Why?
|
| Viral Proteins | 1 | 2018 | 1960 | 0.390 |
Why?
|
| Conserved Sequence | 7 | 2015 | 1236 | 0.390 |
Why?
|
| Molecular Targeted Therapy | 3 | 2020 | 2823 | 0.380 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2010 | 95 | 0.380 |
Why?
|
| Molecular Sequence Data | 14 | 2015 | 18601 | 0.380 |
Why?
|
| RNA, Messenger | 6 | 2022 | 13205 | 0.380 |
Why?
|
| Stem Cells | 4 | 2014 | 3568 | 0.370 |
Why?
|
| Helminth Proteins | 3 | 2007 | 179 | 0.370 |
Why?
|
| Mice, Nude | 5 | 2021 | 3802 | 0.370 |
Why?
|
| Ribonuclease III | 3 | 2017 | 274 | 0.360 |
Why?
|
| Genetic Vectors | 5 | 2019 | 3527 | 0.360 |
Why?
|
| Disease Models, Animal | 10 | 2021 | 18185 | 0.360 |
Why?
|
| Neural Tube | 1 | 2008 | 48 | 0.350 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 1687 | 0.350 |
Why?
|
| Ribosomal Proteins | 2 | 2009 | 354 | 0.350 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13620 | 0.350 |
Why?
|
| Mutation | 18 | 2018 | 29270 | 0.340 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2008 | 52 | 0.340 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 950 | 0.340 |
Why?
|
| Biological Evolution | 3 | 2007 | 1083 | 0.340 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 2807 | 0.340 |
Why?
|
| Phylogeny | 5 | 2021 | 2798 | 0.340 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 6320 | 0.340 |
Why?
|
| Open Reading Frames | 1 | 2012 | 833 | 0.330 |
Why?
|
| Binding Sites | 8 | 2015 | 6212 | 0.330 |
Why?
|
| Microarray Analysis | 3 | 2007 | 776 | 0.330 |
Why?
|
| Medical Oncology | 1 | 2019 | 2120 | 0.320 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2018 | 4907 | 0.320 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2021 | 3631 | 0.320 |
Why?
|
| Pancreatic Neoplasms | 3 | 2022 | 4978 | 0.320 |
Why?
|
| Methyltransferases | 2 | 2021 | 353 | 0.310 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 3050 | 0.310 |
Why?
|
| Endoribonucleases | 1 | 2008 | 219 | 0.310 |
Why?
|
| Clinical Trials, Phase I as Topic | 2 | 2020 | 326 | 0.310 |
Why?
|
| Alleles | 6 | 2021 | 7097 | 0.300 |
Why?
|
| RNA, Double-Stranded | 2 | 2022 | 271 | 0.300 |
Why?
|
| Stress, Physiological | 2 | 2011 | 1425 | 0.300 |
Why?
|
| Genome, Helminth | 3 | 2010 | 14 | 0.290 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 4821 | 0.290 |
Why?
|
| Protein Biosynthesis | 5 | 2018 | 2134 | 0.290 |
Why?
|
| Membrane Proteins | 2 | 2017 | 8035 | 0.290 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2008 | 356 | 0.290 |
Why?
|
| Cell Cycle | 2 | 2012 | 2987 | 0.280 |
Why?
|
| Ribonucleoproteins | 1 | 2008 | 376 | 0.280 |
Why?
|
| Clinical Trials, Phase II as Topic | 2 | 2020 | 629 | 0.280 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2022 | 1510 | 0.280 |
Why?
|
| Disease Management | 1 | 2017 | 2519 | 0.280 |
Why?
|
| Casein Kinase Idelta | 1 | 2005 | 14 | 0.280 |
Why?
|
| Motor Neurons | 1 | 2010 | 803 | 0.280 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2014 | 15609 | 0.260 |
Why?
|
| Models, Genetic | 7 | 2018 | 3526 | 0.250 |
Why?
|
| Tumor Cells, Cultured | 4 | 2021 | 6480 | 0.250 |
Why?
|
| Receptors, Immunologic | 1 | 2010 | 1474 | 0.250 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 1638 | 0.250 |
Why?
|
| Lymphoma, B-Cell | 1 | 2010 | 931 | 0.240 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 3818 | 0.240 |
Why?
|
| Genes, Reporter | 4 | 2016 | 1603 | 0.240 |
Why?
|
| Protein Kinases | 1 | 2010 | 1664 | 0.240 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 2943 | 0.230 |
Why?
|
| Gene Regulatory Networks | 5 | 2021 | 1698 | 0.230 |
Why?
|
| Immunotherapy | 1 | 2018 | 4089 | 0.230 |
Why?
|
| Embryonic Development | 1 | 2008 | 706 | 0.230 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 2212 | 0.230 |
Why?
|
| Cholesterol | 1 | 2012 | 2868 | 0.230 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2002 | 22 | 0.220 |
Why?
|
| Nucleic Acid Conformation | 3 | 2018 | 890 | 0.220 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1373 | 0.210 |
Why?
|
| tRNA Methyltransferases | 1 | 2021 | 51 | 0.210 |
Why?
|
| Sequence Alignment | 3 | 2011 | 2289 | 0.210 |
Why?
|
| RNA Precursors | 2 | 2018 | 213 | 0.210 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2446 | 0.210 |
Why?
|
| Gene Expression | 4 | 2021 | 7950 | 0.210 |
Why?
|
| Feedback, Physiological | 2 | 2017 | 476 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2014 | 853 | 0.210 |
Why?
|
| NF-kappa B | 1 | 2010 | 2553 | 0.200 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2021 | 1356 | 0.200 |
Why?
|
| Signal Transduction | 9 | 2017 | 23721 | 0.200 |
Why?
|
| Up-Regulation | 4 | 2018 | 4305 | 0.200 |
Why?
|
| CDC2 Protein Kinase | 1 | 2021 | 220 | 0.200 |
Why?
|
| Eukaryotic Initiation Factor-3 | 2 | 2018 | 39 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 6276 | 0.200 |
Why?
|
| Reactive Oxygen Species | 2 | 2022 | 2097 | 0.190 |
Why?
|
| Herpesvirus 8, Human | 1 | 2021 | 240 | 0.190 |
Why?
|
| Zinc Fingers | 2 | 2000 | 595 | 0.190 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2017 | 2922 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 336 | 0.180 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2021 | 235 | 0.180 |
Why?
|
| Growth | 2 | 1998 | 395 | 0.180 |
Why?
|
| Lipids | 1 | 2011 | 3247 | 0.180 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1749 | 0.180 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 386 | 0.180 |
Why?
|
| Cell Line | 4 | 2022 | 16574 | 0.180 |
Why?
|
| Evolution, Molecular | 2 | 2010 | 1939 | 0.180 |
Why?
|
| Purines | 1 | 2022 | 592 | 0.170 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1998 | 98 | 0.170 |
Why?
|
| RNA, Transfer, Leu | 1 | 2018 | 9 | 0.170 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 5939 | 0.170 |
Why?
|
| RNA Stability | 1 | 2020 | 298 | 0.170 |
Why?
|
| Histones | 5 | 2021 | 2550 | 0.170 |
Why?
|
| HeLa Cells | 4 | 2014 | 3212 | 0.170 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2021 | 311 | 0.170 |
Why?
|
| Protein Binding | 3 | 2020 | 9559 | 0.160 |
Why?
|
| Disease Progression | 5 | 2021 | 13219 | 0.160 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 497 | 0.160 |
Why?
|
| Oxycodone | 1 | 2019 | 140 | 0.160 |
Why?
|
| Drosophila Proteins | 2 | 2007 | 1748 | 0.160 |
Why?
|
| Thyroid Neoplasms | 2 | 2021 | 2221 | 0.160 |
Why?
|
| Phenotype | 4 | 2009 | 16308 | 0.160 |
Why?
|
| Azacitidine | 1 | 2019 | 298 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2012 | 330 | 0.160 |
Why?
|
| Paraffin Embedding | 1 | 2018 | 318 | 0.160 |
Why?
|
| Adenosine | 1 | 2022 | 816 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 4561 | 0.150 |
Why?
|
| Formaldehyde | 1 | 2018 | 363 | 0.150 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2009 | 1121 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2015 | 17399 | 0.150 |
Why?
|
| Nucleus Accumbens | 1 | 2019 | 358 | 0.150 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2009 | 183 | 0.150 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2021 | 733 | 0.150 |
Why?
|
| Adenoviridae | 2 | 2012 | 1126 | 0.140 |
Why?
|
| Sequence Deletion | 1 | 2020 | 1550 | 0.140 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2017 | 366 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 3 | 2021 | 3681 | 0.130 |
Why?
|
| Stromal Cells | 1 | 2020 | 1337 | 0.130 |
Why?
|
| Multienzyme Complexes | 1 | 1998 | 702 | 0.130 |
Why?
|
| Ribosomes | 1 | 2018 | 503 | 0.130 |
Why?
|
| Point Mutation | 1 | 2020 | 1648 | 0.130 |
Why?
|
| DNA Primers | 2 | 2012 | 2976 | 0.130 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 9848 | 0.130 |
Why?
|
| Drug Design | 1 | 2020 | 1099 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2021 | 5191 | 0.130 |
Why?
|
| Base Pairing | 2 | 2023 | 136 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 1597 | 0.130 |
Why?
|
| Acids | 1 | 2014 | 136 | 0.130 |
Why?
|
| DNA | 3 | 2023 | 7088 | 0.130 |
Why?
|
| Photochemotherapy | 1 | 2020 | 829 | 0.130 |
Why?
|
| Behavior, Addictive | 1 | 2019 | 429 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2018 | 4036 | 0.120 |
Why?
|
| Hydrogels | 1 | 2018 | 629 | 0.120 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2017 | 657 | 0.120 |
Why?
|
| Circadian Rhythm | 1 | 2005 | 2547 | 0.120 |
Why?
|
| Chromatin | 3 | 2021 | 2683 | 0.120 |
Why?
|
| DNA Methylation | 3 | 2021 | 4075 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2011 | 2030 | 0.120 |
Why?
|
| Transfection | 3 | 2020 | 6091 | 0.110 |
Why?
|
| Nanotechnology | 1 | 2018 | 695 | 0.110 |
Why?
|
| Cell Membrane Permeability | 1 | 2014 | 620 | 0.110 |
Why?
|
| Apoptosis | 3 | 2021 | 9962 | 0.110 |
Why?
|
| Drug Stability | 1 | 2013 | 304 | 0.110 |
Why?
|
| Cell Separation | 1 | 2018 | 1819 | 0.110 |
Why?
|
| Mucin-1 | 1 | 2017 | 529 | 0.110 |
Why?
|
| Genes, Switch | 2 | 2003 | 45 | 0.110 |
Why?
|
| Molecular Sequence Annotation | 2 | 2014 | 548 | 0.110 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 7982 | 0.110 |
Why?
|
| Gene Library | 1 | 2015 | 1086 | 0.110 |
Why?
|
| Neointima | 1 | 2012 | 144 | 0.110 |
Why?
|
| Models, Biological | 5 | 2021 | 9815 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 1704 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4267 | 0.110 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 1136 | 0.110 |
Why?
|
| Cancer Vaccines | 1 | 2019 | 996 | 0.110 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2016 | 673 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4889 | 0.100 |
Why?
|
| Fluorescence | 1 | 2013 | 764 | 0.100 |
Why?
|
| Doxycycline | 1 | 2012 | 310 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2021 | 4264 | 0.100 |
Why?
|
| Lymphoid Tissue | 1 | 2012 | 490 | 0.100 |
Why?
|
| Drug Synergism | 1 | 2015 | 1852 | 0.100 |
Why?
|
| Liver Regeneration | 1 | 2012 | 218 | 0.100 |
Why?
|
| Growth and Development | 1 | 2010 | 51 | 0.100 |
Why?
|
| Genetic Markers | 3 | 2011 | 2684 | 0.100 |
Why?
|
| Female | 15 | 2021 | 377052 | 0.100 |
Why?
|
| Cyclin D1 | 1 | 2012 | 468 | 0.090 |
Why?
|
| Endothelium | 1 | 2012 | 802 | 0.090 |
Why?
|
| Cell Lineage | 3 | 2021 | 2595 | 0.090 |
Why?
|
| RNA Polymerase II | 1 | 2014 | 536 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 2600 | 0.090 |
Why?
|
| Amino Acid Sequence | 4 | 2005 | 14171 | 0.090 |
Why?
|
| DNA Helicases | 1 | 2014 | 825 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 313 | 0.090 |
Why?
|
| Cell Dedifferentiation | 1 | 2010 | 138 | 0.090 |
Why?
|
| Time Factors | 6 | 2009 | 40892 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 3 | 2014 | 2015 | 0.090 |
Why?
|
| Disorders of Sex Development | 1 | 2009 | 121 | 0.090 |
Why?
|
| Cloning, Molecular | 3 | 2014 | 4442 | 0.080 |
Why?
|
| Genes, Lethal | 1 | 2008 | 255 | 0.080 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2013 | 580 | 0.080 |
Why?
|
| Dermis | 1 | 2009 | 212 | 0.080 |
Why?
|
| Estrogens | 1 | 2015 | 1529 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 619 | 0.080 |
Why?
|
| cdc25 Phosphatases | 1 | 2007 | 66 | 0.080 |
Why?
|
| Chromosomes | 1 | 2010 | 597 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2016 | 3124 | 0.080 |
Why?
|
| Cell Survival | 2 | 2021 | 6032 | 0.080 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 403 | 0.080 |
Why?
|
| Administration, Intranasal | 1 | 2008 | 458 | 0.070 |
Why?
|
| Genes, BRCA1 | 1 | 2011 | 759 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2010 | 726 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 1 | 2012 | 883 | 0.070 |
Why?
|
| Drosophila melanogaster | 2 | 2014 | 1751 | 0.070 |
Why?
|
| Gene Components | 1 | 2005 | 31 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 966 | 0.070 |
Why?
|
| Liver | 2 | 2012 | 7588 | 0.070 |
Why?
|
| Cell Division | 2 | 2010 | 4694 | 0.070 |
Why?
|
| Hot Temperature | 1 | 2011 | 1322 | 0.070 |
Why?
|
| Environment | 1 | 2012 | 1097 | 0.070 |
Why?
|
| Lentivirus | 1 | 2009 | 535 | 0.070 |
Why?
|
| Neurons, Afferent | 1 | 2008 | 511 | 0.070 |
Why?
|
| beta Catenin | 1 | 2010 | 1037 | 0.070 |
Why?
|
| Prognosis | 3 | 2018 | 28987 | 0.070 |
Why?
|
| Genetic Variation | 3 | 2015 | 6662 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2406 | 0.070 |
Why?
|
| Metabolism | 1 | 2006 | 208 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 1974 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 1414 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2014 | 3882 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2012 | 5371 | 0.060 |
Why?
|
| Haplotypes | 1 | 2011 | 2883 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1626 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 3291 | 0.060 |
Why?
|
| Cytokines | 1 | 2018 | 7190 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2016 | 8078 | 0.060 |
Why?
|
| Proteins | 1 | 1998 | 6080 | 0.060 |
Why?
|
| Organogenesis | 1 | 2005 | 235 | 0.060 |
Why?
|
| Muscles | 1 | 2008 | 1557 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2005 | 4910 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 1991 | 0.060 |
Why?
|
| Homeostasis | 1 | 2014 | 3330 | 0.060 |
Why?
|
| Pharynx | 1 | 2005 | 417 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 11194 | 0.050 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 863 | 0.050 |
Why?
|
| Guanosine | 1 | 2021 | 60 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1987 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2012 | 6095 | 0.050 |
Why?
|
| Genome, Human | 2 | 2021 | 4468 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 13635 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 5070 | 0.050 |
Why?
|
| Phenylthiohydantoin | 1 | 2021 | 191 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 10287 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2014 | 21802 | 0.050 |
Why?
|
| Extremities | 1 | 2005 | 871 | 0.050 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2021 | 292 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 5406 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2005 | 1800 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2008 | 2734 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2021 | 2993 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2010 | 1595 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 10598 | 0.040 |
Why?
|
| Cyclization | 1 | 2018 | 66 | 0.040 |
Why?
|
| Polyribosomes | 1 | 2018 | 120 | 0.040 |
Why?
|
| Methylation | 1 | 2021 | 1097 | 0.040 |
Why?
|
| Microinjections | 1 | 2019 | 367 | 0.040 |
Why?
|
| Zebrafish | 1 | 2010 | 3002 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11665 | 0.040 |
Why?
|
| Cell Movement | 2 | 2021 | 5392 | 0.040 |
Why?
|
| Self Administration | 1 | 2019 | 385 | 0.040 |
Why?
|
| Genome | 1 | 2006 | 1752 | 0.040 |
Why?
|
| Breast Neoplasms | 3 | 2015 | 20060 | 0.040 |
Why?
|
| Mixed Function Oxygenases | 1 | 1998 | 316 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2022 | 1116 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 22648 | 0.040 |
Why?
|
| Virus Activation | 1 | 2019 | 329 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2021 | 1694 | 0.040 |
Why?
|
| Exons | 1 | 2003 | 2463 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1902 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2019 | 477 | 0.040 |
Why?
|
| Nitriles | 1 | 2021 | 944 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2020 | 1351 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2017 | 289 | 0.040 |
Why?
|
| Multigene Family | 1 | 2000 | 1123 | 0.040 |
Why?
|
| Insulin | 1 | 2011 | 6654 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 4929 | 0.040 |
Why?
|
| Retroviridae | 1 | 2019 | 955 | 0.040 |
Why?
|
| Equipment Design | 1 | 2004 | 3587 | 0.040 |
Why?
|
| Organoids | 1 | 2021 | 667 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 1390 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4355 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2021 | 2786 | 0.040 |
Why?
|
| Intestines | 1 | 2005 | 1918 | 0.030 |
Why?
|
| Male | 6 | 2021 | 350156 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2000 | 2397 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2021 | 1049 | 0.030 |
Why?
|
| Protein Transport | 1 | 2021 | 2054 | 0.030 |
Why?
|
| Pupa | 1 | 2014 | 38 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4905 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 2123 | 0.030 |
Why?
|
| Lung | 2 | 2018 | 9733 | 0.030 |
Why?
|
| Software | 1 | 2009 | 4393 | 0.030 |
Why?
|
| Particle Size | 1 | 2018 | 1674 | 0.030 |
Why?
|
| Dependovirus | 1 | 2019 | 732 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2005 | 3034 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2918 | 0.030 |
Why?
|
| Carcinoma | 1 | 2005 | 2320 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2017 | 529 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2008 | 15051 | 0.030 |
Why?
|
| Melanoma | 1 | 2011 | 5246 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2021 | 1285 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 1681 | 0.030 |
Why?
|
| Esters | 1 | 2013 | 211 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2008 | 19905 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 714 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 58288 | 0.030 |
Why?
|
| Caenorhabditis | 1 | 2010 | 38 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2015 | 621 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 613 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2020 | 4228 | 0.020 |
Why?
|
| Vasculitis | 1 | 2012 | 515 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2015 | 1185 | 0.020 |
Why?
|
| Neurons | 1 | 2008 | 9377 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 7261 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2019 | 2708 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2767 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 162383 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 25191 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1998 | 5098 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 40042 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 214618 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 6633 | 0.010 |
Why?
|
| Rats | 1 | 2019 | 24802 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 3670 | 0.010 |
Why?
|
| DNA, Helminth | 1 | 2000 | 37 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 2000 | 205 | 0.010 |
Why?
|
| Computational Biology | 1 | 2010 | 3569 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19528 | 0.010 |
Why?
|
| Species Specificity | 1 | 2000 | 2593 | 0.010 |
Why?
|
| Risk | 1 | 2008 | 9812 | 0.010 |
Why?
|
| African Americans | 1 | 2011 | 4991 | 0.010 |
Why?
|
| Genomics | 1 | 2010 | 5338 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 8950 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 70927 | 0.010 |
Why?
|
| Adult | 2 | 2010 | 212228 | 0.000 |
Why?
|